Dimensional Fund Advisors LP Denali Therapeutics Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,559,442 shares of DNLI stock, worth $38.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,559,442
Previous 1,417,472 10.02%
Holding current value
$38.2 Million
Previous $32.9 Million 38.02%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$20.96 - $31.05 $2.98 Million - $4.41 Million
141,970 Added 10.02%
1,559,442 $45.4 Million
Q2 2024

Aug 09, 2024
BUY
$14.96 - $23.22 $1.26 Million - $1.96 Million
84,522 Added 6.34%
1,417,472 $32.9 Million
Q1 2024

May 10, 2024
BUY
$15.83 - $23.35 $3.38 Million - $4.98 Million
213,322 Added 19.05%
1,332,950 $27.4 Million
Q4 2023

Feb 07, 2024
BUY
$16.2 - $23.18 $2.37 Million - $3.39 Million
146,394 Added 15.04%
1,119,628 $24 Million
Q3 2023

Nov 09, 2023
BUY
$20.63 - $30.17 $4.51 Million - $6.59 Million
218,433 Added 28.94%
973,234 $20.1 Million
Q2 2023

Aug 09, 2023
BUY
$23.37 - $32.96 $2.98 Million - $4.2 Million
127,476 Added 20.32%
754,801 $22.3 Million
Q1 2023

May 12, 2023
BUY
$21.91 - $32.67 $1.51 Million - $2.26 Million
69,067 Added 12.37%
627,325 $14.5 Million
Q4 2022

Feb 09, 2023
SELL
$26.28 - $33.92 $1.36 Million - $1.75 Million
-51,581 Reduced 8.46%
558,258 $15.5 Million
Q3 2022

Nov 10, 2022
SELL
$25.97 - $38.53 $7.32 Million - $10.9 Million
-281,839 Reduced 31.61%
609,839 $18.7 Million
Q2 2022

Aug 12, 2022
BUY
$20.88 - $35.19 $280,919 - $473,446
13,454 Added 1.53%
891,678 $26.2 Million
Q1 2022

May 13, 2022
BUY
$29.0 - $47.27 $3.07 Million - $5.01 Million
106,027 Added 13.73%
878,224 $28.3 Million
Q4 2021

Feb 09, 2022
BUY
$42.59 - $55.02 $5.85 Million - $7.56 Million
137,462 Added 21.66%
772,197 $34.4 Million
Q3 2021

Nov 12, 2021
BUY
$48.48 - $78.23 $15 Million - $24.2 Million
309,387 Added 95.09%
634,735 $32 Million
Q2 2021

Aug 12, 2021
SELL
$50.3 - $78.44 $4.82 Million - $7.52 Million
-95,854 Reduced 22.76%
325,348 $25.5 Million
Q1 2021

May 14, 2021
SELL
$53.8 - $81.53 $1.7 Million - $2.57 Million
-31,578 Reduced 6.97%
421,202 $24 Million
Q4 2020

Feb 25, 2021
BUY
$36.89 - $93.56 $16.7 Million - $42.4 Million
452,780 New
452,780 $37.9 Million

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.29B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email